Literature DB >> 2209705

Idiotypic interactions between normal human polyspecific IgG and natural IgM antibodies.

F Rossi1, B Guilbert, C Tonnelle, T Ternynck, F Fumoux, S Avrameas, M D Kazatchkine.   

Abstract

Pooled normal human polyspecific IgG (IVIg) contain anti-idiotypes against a variety of autoantibodies from patients with autoimmune diseases and IgG autoantibodies present in IVIg. The present study indicates that IVIg may also react through idiotypic/anti-idiotypic interactions with human natural IgM antibodies. Sixty-four percent of IgM secreted by B lymphoid cell lines derived from B cells of healthy elderly donors and 18% of IgM secreted by cloned EBV-transformed cord B cells that were tested, bound through their variable region to F(ab')2 fragments of IVIg. The binding to 2,4,6-trinitrophenyl (TNP) of a polyreactive IgM with anti-TNP specificity, was inhibited by F(ab')2 fragments from IVIg, indicating the presence in IVIg of anti-idiotypes that may interfere with the antibody-combining site of polyreactive IgM antibodies. The ability of IgM antibodies to interact with idiotypes on IVIg was not related to the degree of polyreactivity of natural antibodies. Our observations further document that IVIg contain antibody specificities against Ig from normal individuals and suggest that IgG originating from the physiologically expressed repertoire may modulate the expression of the potential B cell repertoire. The results may be relevant to the suppressive effect of IVIg in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209705     DOI: 10.1002/eji.1830200930

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

Authors:  S V Kaveri; G Dietrich; V Hurez; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Intravenous immunoglobulins. Current understanding and future directions.

Authors:  S Jolles; S V Kaveri; J Orange
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

3.  Autoreactive sites of human lambda light chain mapped by comprehensive peptide synthesis.

Authors:  H Kaymaz; J J Marchalonis
Journal:  J Protein Chem       Date:  1993-12

4.  Inverse correlation between IgG-antihinge region and antierythrocyte autoantibody in chronic benign and malignant cold agglutination.

Authors:  P Terness; M Kirschfink; D Navolan; L Moroder; F Siedler; D Drugarin; F Schneider; C Dufter; I Kohl; M Welschof; G Opelz; D Roelcke
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

5.  Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

Authors:  T Vassilev; C Gelin; S V Kaveri; M T Zilber; L Boumsell; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

6.  Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin.

Authors:  A A Pall; M Varagunam; D Adu; N Smith; N T Richards; C M Taylor; J Michael
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Molecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries.

Authors:  R Finnern; J M Bye; K M Dolman; M H Zhao; A Short; J D Marks; M C Lockwood; W H Ouwehand
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

8.  Common idiotypes expressed on human, monoclonal, abnormal immunoglobulins and cryoglobulins with polyreactive autoantibody activities.

Authors:  M R Barbouche; B Guilbert; S Makni; Y Gorgi; K Ayed; S Avrameas
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

9.  Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.

Authors:  F Rossi; D R Jayne; C M Lockwood; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

10.  Human anti-self antibodies with high specificity from phage display libraries.

Authors:  A D Griffiths; M Malmqvist; J D Marks; J M Bye; M J Embleton; J McCafferty; M Baier; K P Holliger; B D Gorick; N C Hughes-Jones
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.